Ellsworth Advisors, LLC Ligand Pharmaceuticals Inc Transaction History
Ellsworth Advisors, LLC
- $389 Million
- Q2 2025
A detailed history of Ellsworth Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Ellsworth Advisors, LLC holds 7,327 shares of LGND stock, worth $1.12 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
7,327
Previous 7,272
0.76%
Holding current value
$1.12 Million
Previous $764,000
8.9%
% of portfolio
0.21%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding LGND
# of Institutions
284Shares Held
18.9MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$438 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$319 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$157 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$138 Million0.12% of portfolio
-
State Street Corp Boston, MA727KShares$111 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.58B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...